Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific Officer (CSO), effective July 20, 2026. In ...
Bionano Genomics (NASDAQ:BNGO) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...
Bionano Genomics (NASDAQ:BNGO) will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bionano ...
Bionano Genomics, Inc. (BNGO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
Hosted on MSN
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...
Bionano Genomics Inc (NASDAQ:BNGO) is set to release its Q1 2026 earnings on May 13, 2026. The consensus estimate for Q1 2026 revenue is $6.57 million, and the earnings are expected to come in at ...
Image source: The Motley Fool. Management attributed revenue softness to supply constraints in consumables, not demand weakness, and indicated expected recovery as manufacturing delays are resolved.
Operator: Good day and thank you for standing by. Welcome to the Bionano Q2 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there ...
Bionano said it expected revenue of $7.3 million to $7.5 million in the first quarter, representing an increase of 28% to 32%, year over year. That would also mean the 10th consecutive quarter of ...
Bionano Genomics Inc BNGO shares continue to trade higher Wednesday after the company on Tuesday highlighted a study showing that optical genome mapping better detected structural variations in liver ...
Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results